Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$9.63M Buy
271,398
+10,900
+4% +$405K 0.54% 53
2014
Q2
$10.2M Buy
260,498
+5,104
+2% +$191K 0.57% 50
2014
Q1
$9.3M Buy
255,394
+1,400
+0.6% +$51.1K 0.58% 49
2013
Q4
$8.79M Buy
253,994
+330
+0.1% +$10.6K 0.58% 48
2013
Q3
$7.08M Buy
253,664
+12,115
+5% +$323K 0.56% 48
2013
Q2
$6.51M Buy
+241,549
New +$6.67M 0.52% 57

Other funds holding XYL

McAdams Wright Ragen's XYL Position: Q3 2014 in Review

McAdams Wright Ragen increased its Xylem (XYL) stake by 4.2% in Q3 2014, buying an estimated $405K and bringing the position to 271,398 shares worth $9.63M. The position accounts for 0.54% of the portfolio, ranked #53.

McAdams Wright Ragen first reported a position in XYL in Q2 2013 and has held it in 6 quarters since. The position peaked at $10.2M in Q2 2014. 439 funds tracked by Wall St. Rank hold XYL as of Q3 2014.

  • McAdams Wright Ragen held 271,398 shares of Xylem worth $9.63M as of Q3 2014.
  • McAdams Wright Ragen bought 10,900 Xylem shares in Q3 2014, an estimated $405K.
  • Xylem made up 0.54% of McAdams Wright Ragen's portfolio in Q3 2014, its #53 holding.
  • McAdams Wright Ragen first reported a position in Xylem in Q2 2013 and has held it in 6 quarters since.
  • McAdams Wright Ragen's Xylem position peaked at $10.2M in Q2 2014.
  • 439 funds tracked by Wall St. Rank held Xylem as of Q3 2014.

Based on McAdams Wright Ragen's 13F filing for Q3 2014, filed 14 Nov 2014.